AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
56.84
+0.86 (1.54%)
At close: Nov 13, 2026, 4:00 PM EST
57.49
+0.65 (1.14%)
Pre-market: Nov 16, 2026, 9:04 AM EST

AtriCure Statistics

Total Valuation

AtriCure has a market cap or net worth of $2.89 billion. The enterprise value is $2.80 billion.

Market Cap2.89B
Enterprise Value 2.80B

Important Dates

The last earnings date was Tuesday, November 3, 2026, after market close.

Earnings Date Nov 3, 2026
Ex-Dividend Date n/a

Share Statistics

AtriCure has 50.92 million shares outstanding. The number of shares has increased by 3.13% in one year.

Current Share Class 50.92M
Shares Outstanding 50.92M
Shares Change (YoY) +3.13%
Shares Change (QoQ) +1.97%
Owned by Insiders (%) 3.98%
Owned by Institutions (%) 108.74%
Float 48.89M

Valuation Ratios

The trailing PE ratio is 185.09 and the forward PE ratio is 167.97.

PE Ratio 185.09
Forward PE 167.97
PS Ratio 4.91
Forward PS 4.38
PB Ratio 5.43
P/TBV Ratio 11.24
P/FCF Ratio 54.68
P/OCF Ratio 42.23
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 73.41, with an EV/FCF ratio of 52.97.

EV / Earnings 188.42
EV / Sales 4.75
EV / EBITDA 73.41
EV / EBIT 164.62
EV / FCF 52.97

Financial Position

The company has a current ratio of 4.33, with a Debt / Equity ratio of 0.18.

Current Ratio 4.33
Quick Ratio 3.13
Debt / Equity 0.18
Debt / EBITDA 2.41
Debt / FCF 1.83
Interest Coverage 2.95

Financial Efficiency

Return on equity (ROE) is 2.95% and return on invested capital (ROIC) is 3.62%.

Return on Equity (ROE) 2.95%
Return on Assets (ROA) 1.57%
Return on Invested Capital (ROIC) 3.62%
Return on Capital Employed (ROCE) 2.69%
Weighted Average Cost of Capital (WACC) 10.73%
Revenue Per Employee $436,891
Profits Per Employee $11,024
Employee Count1,350
Asset Turnover 0.87
Inventory Turnover 1.65

Taxes

In the past 12 months, AtriCure has paid $1.31 million in taxes.

Income Tax 1.31M
Effective Tax Rate 8.11%

Stock Price Statistics

The stock price has increased by +71.93% in the last 52 weeks. The beta is 1.21, so AtriCure's price volatility has been higher than the market average.

Beta (5Y) 1.21
52-Week Price Change +71.93%
50-Day Moving Average 57.48
200-Day Moving Average 39.09
Relative Strength Index (RSI) 46.55
Average Volume (20 Days) 790,421

Short Selling Information

The latest short interest is 4.89 million, so 9.60% of the outstanding shares have been sold short.

Short Interest 4.89M
Short Previous Month 4.89M
Short % of Shares Out 9.60%
Short % of Float 10.00%
Short Ratio (days to cover) 5.99

Income Statement

In the last 12 months, AtriCure had revenue of $589.80 million and earned $14.88 million in profits. Earnings per share was $0.31.

Revenue589.80M
Gross Profit 452.63M
Operating Income 17.04M
Pretax Income 16.20M
Net Income 14.88M
EBITDA 38.20M
EBIT 17.04M
Earnings Per Share (EPS) $0.31
Full Income Statement

Balance Sheet

The company has $187.03 million in cash and $96.83 million in debt, with a net cash position of $90.20 million or $1.77 per share.

Cash & Cash Equivalents 187.03M
Total Debt 96.83M
Net Cash 90.20M
Net Cash Per Share $1.77
Equity (Book Value) 533.22M
Book Value Per Share 10.47
Working Capital 279.42M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $68.55 million and capital expenditures -$15.61 million, giving a free cash flow of $52.94 million.

Operating Cash Flow 68.55M
Capital Expenditures -15.61M
Depreciation & Amortization 21.16M
Net Borrowing -2.18M
Free Cash Flow 52.94M
FCF Per Share $1.04
Full Cash Flow Statement

Margins

Gross margin is 76.74%, with operating and profit margins of 2.89% and 2.52%.

Gross Margin 76.74%
Operating Margin 2.89%
Pretax Margin 2.75%
Profit Margin 2.52%
EBITDA Margin 6.48%
EBIT Margin 2.89%
FCF Margin 8.98%

Dividends & Yields

AtriCure does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -3.13%
Shareholder Yield -3.13%
Earnings Yield 0.54%
FCF Yield 1.83%

Analyst Forecast

The average price target for AtriCure is $64.89, which is 14.16% higher than the current price. The consensus rating is "Buy".

Price Target $64.89
Price Target Difference 14.16%
Analyst Consensus Buy
Analyst Count 10
Revenue Growth Forecast (3Y) 12.72%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

AtriCure has an Altman Z-Score of 6.49 and a Piotroski F-Score of 8.

Altman Z-Score 6.49
Piotroski F-Score 8